Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis
Conditions: Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: Pyrotinib Plus And; Drug: Trastuzumab; Drug: Abraxane Sponsor: Shandong Cancer Hospital and Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abraxane | Brain | Brain Cancers | Cancer | Cancer & Oncology | HER2 | Herceptin | Neurology | Research